Evidence map›Paper›PMID 39112961›Full record

ArticleBMC oral health2024

Chronic nonspecific cheilitis associated with tislelizumab treatment in a patient with a history of tongue squamous cell carcinoma: a case report.

Haiyue Yu, Qiao Ruan, Liyi Jiang

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC oral health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Haiyue YuStomatological Hospital, School of Stomatology, Southern Medical University, 366# Southern Jiangnan Road, Guangzhou, Guangdong, 510280, China.
Qiao RuanStomatological Hospital, School of Stomatology, Southern Medical University, 366# Southern Jiangnan Road, Guangzhou, Guangdong, 510280, China.
Liyi JiangStomatological Hospital, School of Stomatology, Southern Medical University, 366# Southern Jiangnan Road, Guangzhou, Guangdong, 510280, China. 1606168002@qq.com.

Funding

Science Research Cultivation Program of Stomatological Hospital, Southern Medical University PY2021026
6 · The paper itself

Abstract

backgroundChronic nonspecific cheilitis is a complex condition characterized by persistent lip peeling and discomfort. This case report explores the clinical progression of a patient with history of tongue squamous cell carcinoma and subsequent Tislelizumab treatment, presenting with persistent lip peeling. CASE PRESENTATION: A patient with a history of tongue squamous cell carcinoma (T

conclusionsThis case underscores the importance of recognizing and managing oral manifestations in patients with a history of cancer and immunotherapy. The patient's response to treatment suggests that a multifaceted approach, combining local therapy with lifestyle modifications, can be effective in managing chronic nonspecific cheilitis associated with immunotherapy. Routine follow-up appointments, guided by personalized medicine principles, contribute to sustained patient well-being.

Indexed as

Antibodies, Monoclonal, HumanizedCarcinoma, Squamous CellCheilitisTongue NeoplasmsCandidiasis, OralChronic DiseaseHumansAntibodies, Monoclonal, HumanizedChronic nonspecific cheilitisImmunotherapyMultidisciplinary approachOral manifestationsTislelizumab

Identifiers

PMID39112961
PMCPMC11308578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.